Advanced search
Companies (534)
T-Mobile US, Inc. specializes in mobile telecommunication services. Sales break down by activity as follows: - mobile telecommunication services (80.5%): mobile telephone service, long-distance telephone service, data transmission, Internet access, direc ...
Capitalization | 203 B USD |
---|---|
Change | +2.77% |
1-year price change | +10.95% |
AT&T Inc. is one of the leading American telecommunication operators. The activity is organized mainly around two areas: - mobile telephony; - fixed telephony and cable services: local and long-distance telephony services. The group also offers broadban ...
Capitalization | 129 B USD |
---|---|
Change | +1.89% |
1-year price change | +9.36% |
Ferrari N.V. is a holding company organized around 3 areas of activity: - manufacturing and sale of luxury sports vehicles (85.8% of net sales): 458 Italia, 488 GTB, 458 Spider, 488 Spider, F12 Berlinetta, 458 Speciale, 458 Speciale A, California T and F ...
Capitalization | 73 587 M USD |
---|---|
Change | +0.41% |
1-year price change | +21.37% |
T. Rowe Price Group, Inc. is an investment management company that provides investment advisory services to individual and institutional investors, retirement plans, and financial intermediaries. The group manages a broad range of American and internation ...
Capitalization | 26 088 M USD |
---|---|
Change | -0.21% |
1-year price change | +8.26% |
Alnylam Pharmaceuticals, Inc. is a clinical-stage company. The Company is engaged in developing mRNA cell therapies for the treatment of autoimmune diseases. The Companyâs lead product candidate, Descartes-08, is an autologous mRNA CAR-T directed agains ...
Capitalization | 19 031 M USD |
---|---|
Change | -0.49% |
1-year price change | -21.78% |
Telstra Group Limited is an Australia-based telecommunications and technology company, offering a full range of communications services. The Companyâs segments include Telstra Consumer and Small Business (TC&SB), Telstra Enterprise (TE), Networks, IT an ...
Capitalization | 26 763 M USD |
---|---|
Change | +1.72% |
1-year price change | -10.61% |
Chow Tai Fook Jewellery Group Limited specializes in the design, manufacture and marketing of luxury jewelry in platinum, gold and precious stones (sapphire, diamond, ruby, etc.). The group offers necklaces, earrings, rings, bracelets, pendants, etc. (Cho ...
Capitalization | 12 696 M USD |
---|---|
Change | +1.20% |
1-year price change | -12.39% |
M&T Bank Corporation is a banking group organized around 7 business sectors: - retail banking (29.4% of net interest income): sales of standard and specialized banking products and services (leasing, factoring, insurance, etc.); - commercial banking (22 ...
Capitalization | 24 745 M USD |
---|---|
Change | -1.21% |
1-year price change | +6.88% |
lululemon athletica Inc. specializes in the design and marketing of technical sportswear for men and women. The group offers pants, t-shirts, shorts, jerseys, jackets, etc. as well as accessories (socks, shoes, rugs, bags, water bottles, etc.). Net sales ...
Capitalization | 38 607 M USD |
---|---|
Change | +0.07% |
1-year price change | -39.99% |
Samsung C&T Corp is a Korea-based company principally engaged in the trading of industrial goods. The Company operates its business through six segments. The Trading segment is mainly engaged in the trading of chemicals, steel, natural materials, and livi ...
Capitalization | 16 324 M USD |
---|---|
Change | -2.38% |
1-year price change | +4.56% |
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell ...
Capitalization | 24 824 M USD |
---|---|
Change | -3.35% |
1-year price change | -5.80% |
Keurig Dr Pepper Inc. is is a leading producer of non-alcoholic beverages in North America. The group markets hot drinks, soft drinks, flavoured water, fruit juices, concentrated and syrups. Net sales break down by family of products as follows: - refres ...
Capitalization | 46 591 M USD |
---|---|
Change | +1.29% |
1-year price change | +4.49% |
T&D Holdings, Inc. is a holding company detaining shares in the life insurance companies Taiyo Life, Daido Life and T&D Financial Life. ...
Capitalization | 9 673 M USD |
---|---|
Change | -2.88% |
1-year price change | +20.26% |
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), refe ...
Capitalization | 7 297 M USD |
---|---|
Change | +3.20% |
1-year price change | -31.34% |
GlaxoSmithKline Pharmaceuticals Limited is an India-based global healthcare company. The Company is engaged in the business of manufacturing, distributing and trading in pharmaceuticals. It has three product areas: vaccines, specialty and general medicine ...
Capitalization | 5 081 M USD |
---|---|
Change | -5.19% |
1-year price change | +24.56% |
Regional Express Holdings Limited is an Australia-based company engaged in the provision of air services, including the transportation of passengers and freight, along with aeromedical services and pilot training. The Company's segments include regular pu ...
Capitalization | 52 M USD |
---|---|
Change | +1.46% |
1-year price change | -19.19% |
HLA GROUP CORP LTD, formerly Hla Corp Ltd, is a China-based company, principally engaged in the operation of branded garments, and the production and sales of high-end suits and business wear. The operations of branded garments include the management of b ...
Capitalization | 6 307 M USD |
---|---|
Change | +2.63% |
1-year price change | +31.54% |
BAIC BluePark New Energy Technology Co Ltd is a China-based company mainly engaged in the research, development, design, manufacturing, sales and service of pure electric passenger vehicles. The Company mainly owns the two brands of Jihu and BEIJING. Its ...
Capitalization | 5 526 M USD |
---|---|
Change | -2.37% |
1-year price change | +14.36% |
J&T Global Express Ltd is a China-based company principally engaged in global logistics services. The Company's businesses include express delivery services, cross-border logistics services, sales accessories and other services. The express delivery servi ...
Capitalization | 8 936 M USD |
---|---|
Change | -0.75% |
1-year price change | -49.43% |
Valmont Industries, Inc. is a manufacturer of products and services for infrastructure and agricultural markets. The Company operates through two segments: Infrastructure and Agriculture. The Infrastructure segment consists of the manufacture and distribu ...
Capitalization | 5 042 M USD |
---|---|
Change | -1.20% |
1-year price change | +5.65% |
L&T Technology Services Limited is an India-based engineering research and development (ER&D) services provider. The Company offers consultancy, design, development and testing services across the product and process development life cycle. The Company op ...
Capitalization | 5 702 M USD |
---|---|
Change | -1.41% |
1-year price change | -15.93% |
Li Ning Company Limited is specialized in designing, manufacturing and marketing clothing, shoes and sports equipment. The group offers products under its own brand (LI-NING) and licensed brands (Double Happiness, AIGLE, Danskin, Kason and Lotto). Net sal ...
Capitalization | 6 721 M USD |
---|---|
Change | +0.96% |
1-year price change | +0.48% |
Five Below, Inc. is a specialty value retailer offering merchandise targeted at the tween and teen demographic. Its assortment of products, including select brands and licensed merchandise. It is engaged in offering a group of products, including leisure, ...
Capitalization | 7 768 M USD |
---|---|
Change | -1.98% |
1-year price change | -35.28% |
Medigene AG is a Germany-based biotechnology company that develops treatment platforms to target various types and stages of cancer with candidates in clinical and pre-clinical development. The Company focuses on the development of personalized T cell-bas ...
Capitalization | 39 M USD |
---|---|
Change | +0.82% |
1-year price change | -19.34% |
Gildan Activewear Inc. is a vertically integrated manufacturer of everyday basic apparel, including activewear, underwear, and hosiery products. Its primary product categories include activewear tops and bottoms (activewear), socks (hosiery), and underwea ...
Capitalization | 6 358 M USD |
---|---|
Change | -1.13% |
1-year price change | +15.93% |
TSTE Public Company Limited, formerly Thai Sugar Terminal Public Company Limited, is a Thailand-based company, which is a provider of logistics services. It operates businesses relating to transfer and transportation services for sugar and certain agricul ...
Capitalization | 117 M USD |
---|---|
Change | 0.00% |
1-year price change | +18.52% |
Autolus Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing programmed T cell therapies for the treatment of cancer and autoimmune diseases. It is focused on chimeric antigen receptor (CAR)-T cell therapy. Using ...
Capitalization | 1 197 M USD |
---|---|
Change | -6.89% |
1-year price change | -34.94% |
Curocell Inc is a Korea-based company principally engaged in the manufacture, research and development (R&D) of drugs. The Company is also engaged in the development of novel chimeric antigen receptor (CAR)-T therapy technologies targeting novel cancer an ...
Capitalization | 324 M USD |
---|---|
Change | +0.16% |
1-year price change | -11.73% |
TC BioPharm Limited is a clinical-stage cell therapy company. The Company is engaged in developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infecti ...
Capitalization | 5 M USD |
---|---|
Change | +1.41% |
1-year price change | -65.93% |
CERo Therapeutics Holdings, Inc. is an immunotherapy company advancing the development of engineered T cell therapeutics for the treatment of cancer. The Companyâs proprietary approach to T cell engineering, enables it to integrate certain desirable cha ...
Capitalization | 14 M USD |
---|---|
Change | -2.16% |
1-year price change | -91.77% |
Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company. The Company is a developer of T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with s ...
Capitalization | 70 M USD |
---|---|
Change | -2.51% |
1-year price change | +9.91% |
Lux Industries Limited is an India-based company, which is primarily engaged in the business of manufacturing knitted garments. The Company's products include men's, women's and kids' innerwear, winterwear, socks and slacks for women in varied colors and ...
Capitalization | 526 M USD |
---|---|
Change | -10.48% |
1-year price change | +0.06% |
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. The Company is focused on providing cell therapies to people with cancer. Its engineered T-cell receptor (TCR) platform enables the engineering of T-cells to target and destroy ca ...
Capitalization | 273 M USD |
---|---|
Change | -6.54% |
1-year price change | +26.10% |
TScan Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of T cell receptor-engineered T cell (TCR-T), therapies for the treatment of patients with cancer. The Companyâs lead TCR-T therapy c ...
Capitalization | 448 M USD |
---|---|
Change | -1.18% |
1-year price change | +43.74% |
CytoMed Therapeutics Limited is a pre-clinical biopharmaceutical company. The Company is focused on harnessing its licensed proprietary technologies to create cell-based immunotherapies for the treatment of human cancers. The development of its technologi ...
Capitalization | 25 M USD |
---|---|
Change | -5.61% |
1-year price change | -58.78% |
Kaltura, Inc. is a video technology provider. The Company's segments include Enterprise, Education, and Technology (EE&T) and Media and Telecom (M&T). The EE&T segment represents products related to industry solutions for education customers, and media se ...
Capitalization | 150 M USD |
---|---|
Change | 0.00% |
1-year price change | -47.69% |
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on translating medical breakthroughs in cell and gene therapies into potential cures for cancers and rare genetic diseases. The Company has partnered with medical institutions to adva ...
Capitalization | 5 M USD |
---|---|
Change | +4.24% |
1-year price change | -86.17% |
Magyar Telekom Tavkozlesi Nyrt is engaged in providing fixed line and mobile telecommunication services for public and business customers. The Company's segments include Telekom Hungary, T-Systems, Macedonia and Montenegro. Its Telekom Hungary segment ope ...
Capitalization | 2 578 M USD |
---|---|
Change | -0.91% |
1-year price change | +43.99% |
Gracell Biotechnologies Inc is a China-based clinical-stage biopharmaceutical company focused on discovering and developing cell therapies for the treatment of cancers. The Company is primarily focused on disrupting conventional approaches to chimeric ant ...
Capitalization | 991 M USD |
---|---|
Change | +0.05% |
1-year price change | +2.09% |
T&R Biofab Co., Ltd. is a Korea-based company mainly engaged in the production and sale of bioresorbable scaffolds. The bioresorbable scaffolds are sold under the name of T&R mesh and T&R Dental Mesh. In addition, the Company is involved in the production ...
Capitalization | 107 M USD |
---|---|
Change | -1.17% |
1-year price change | -24.52% |
SNTEnergy Co Ltd, formerly S&T Corp, is a Korea-based company engaged in the manufacture and sale of heat exchangers. The Company manufactures heat exchangers, which are used for petrochemical plants, oil refining plants, gas plants and others; heat recov ...
Capitalization | 131 M USD |
---|---|
Change | +11.74% |
1-year price change | +53.14% |
SNT Holdings Co Ltd, formerly S&T Holdings Co Ltd, is a Korea-based holding company engaged in the management of its subsidiaries. Through its subsidiaries, the Company operates in four business divisions: automobile parts division, which manufactures axl ...
Capitalization | 233 M USD |
---|---|
Change | -2.26% |
1-year price change | +25.22% |
Rectifier Technologies Limited is an Australia-based company, which designs and manufactures high-efficiency power rectifiers and produces electronic and specialized magnetic components. The Company's segments include Electronic Components, Industrial Pow ...
Capitalization | 8 M USD |
---|---|
Change | -10.00% |
1-year price change | -75.00% |
Anixa Biosciences, Inc. is a biotechnology company developing vaccines and therapies that are focused on critical unmet needs in oncology. Its segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Other. Its vaccine programs in ...
Capitalization | 82 M USD |
---|---|
Change | -0.78% |
1-year price change | -34.28% |
IN8bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of gamma-delta T cell-based immunotherapies for cancer patients. Gamma-delta T cells are a specialized population of T c ...
Capitalization | 48 M USD |
---|---|
Change | +12.84% |
1-year price change | -10.87% |
Adicet Bio, Inc. is a clinical stage biotechnology company. The Company is engaged in advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. Its lead produc ...
Capitalization | 118 M USD |
---|---|
Change | -5.56% |
1-year price change | -28.04% |
NCR Atleos Corporation is a financial technology company providing self-directed banking solutions to a global customer base, including financial institutions, merchants, manufacturers, retailers and consumers. The Company's solutions enable the accelerat ...
Capitalization | 2 001 M USD |
---|---|
Change | -3.50% |
1-year price change | +10.25% |
Guobo Electronics Co Ltd is a China-based company mainly engaged in the research and development, production and sales of active phased array transmitter and receiver (T/R) components and radio frequency integrated circuits related products. The Company's ...
Capitalization | 4 077 M USD |
---|---|
Change | +1.71% |
1-year price change | -5.60% |
Allogene Therapeutics, Inc. is a clinical-stage immuno-oncology company. The Company is focused on development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. It is focused on four core p ...
Capitalization | 524 M USD |
---|---|
Change | -6.97% |
1-year price change | -27.26% |
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company. The Company specializes in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. It h ...
Capitalization | 36 M USD |
---|---|
Change | -9.68% |
1-year price change | -33.82% |
Connect Biopharma Holdings Limited is a global clinical-stage biopharmaceutical company focused on improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research. It is building ...
Capitalization | 93 M USD |
---|---|
Change | -3.30% |
1-year price change | +38.98% |
Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to ha ...
Capitalization | 313 M USD |
---|---|
Change | +1.67% |
1-year price change | -44.55% |
CARGO Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in advancing curative cell therapies for cancer patients. Its programs, platform technologies, and manufacturing strategy are designed to directly address the chime ...
Capitalization | 747 M USD |
---|---|
Change | +1.06% |
1-year price change | -17.14% |
Celyad Oncology SA is a biotechnology company focused on the discovery and development of innovative technologies chimeric antigen receptor (CAR) T-cell therapies. The company is focusing on opportunities to fully harness the true potential of its proprie ...
Capitalization | 14 M USD |
---|---|
Change | +0.99% |
1-year price change | -21.15% |
International Knitwear Limited is a Pakistan-based company that is engaged in creating, developing and manufacturing knitted and woven apparel products. The Company is also engaged in the export of garments. Its product categories include men's wear, ladi ...
Capitalization | 503 997 USD |
---|---|
Change | -.--% |
1-year price change | -14.71% |
Kyverna Therapeutics, Inc. is a patient-centered, clinical-stage biopharmaceutical company. The Company is focused on developing cell therapies for patients suffering from autoimmune diseases. The Company's lead program, KYV-101, is an autologous CD19 CAR ...
Capitalization | 564 M USD |
---|---|
Change | -0.70% |
1-year price change | 0.00% |
Cabaletta Bio, Inc. is a clinical-stage biotechnology company. The Company is focused on the discovery and development of engineered T cell therapies that have the potential to provide deep and durable, perhaps curative, responses with one-time administra ...
Capitalization | 483 M USD |
---|---|
Change | -0.75% |
1-year price change | -56.23% |
Mafia Trends Limited is an India-based company that is engaged in the business of trading of apparels and readymade garments. The Company is involved in the business of marketing and selling of men's fashion, which includes apparels such as jeans, t-shirt ...
Capitalization | 871 627 USD |
---|---|
Change | -4.96% |
1-year price change | -9.23% |
M&T 1997 as is a Czech Republic-based company primarily engaged in appliances, tools and housewares business industry. The Company is a producer and designer of various sizes and shapes, brass handles, door fittings and window fittings under the M & T bra ...
Capitalization | 17 M USD |
---|---|
Change | -.--% |
1-year price change | -6.25% |
Sanu Gold Corp. is a Canada-based junior mineral exploration-stage company. The Company is exploring three gold exploration permits. Its projects include Bantabaye, Daina and Diguifara. The Bantabaye is located within the Siguiri Basin, approximately 70 k ...
Capitalization | 8 M USD |
---|---|
Change | 0.00% |
1-year price change | -5.56% |
Garment Mantra Lifestyle Limited is an India-based company engaged in the business of manufacturing, selling and distribution of fabrics, hosiery garments and providing related services. The Company offer a range of fabric types and can apply coatings or ...
Capitalization | 6 M USD |
---|---|
Change | -4.89% |
1-year price change | +7.43% |
Thai Energy Storage Technology PCL is a Thailand-based company, which is engaged in the manufacturing and distribution of batteries. The Companyâs product categories include automotive battery, traction battery, EB battery, lighting battery, and golf ca ...
Capitalization | 113 M USD |
---|---|
Change | +0.47% |
1-year price change | +26.19% |
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing a T-Cell Test technologies with the intention of providing an immunology profiling ...
Capitalization | 2 M USD |
---|---|
Change | +1.92% |
1-year price change | -27.40% |
Super Fine Knitters Ltd is engaged in the business of manufacturing knitted apparel/fabrics for itself as well as for national and international brands. It is a supplier of knitted fabrics for companies in India involved in manufacturing and exporting kni ...
Capitalization | 2 M USD |
---|---|
Change | +5.00% |
1-year price change | -3.00% |
Immunotech Biopharm Ltd is a China-based investment holding company mainly engaged in the research and development, manufacturing and commercialization of immune cell products for treatments of cancers. Its main products are EAL, CAR-T cell series and TCR ...
Capitalization | 207 M USD |
---|---|
Change | -4.59% |
1-year price change | -41.80% |
PDS Biotechnology Corporation is a clinical-stage immunotherapy company. The Company is developing a pipeline of targeted cancer immunotherapies based on its Versamune T cell-activator and Versamune in combination with its interleukin 12 (IL-12) fused ant ...
Capitalization | 107 M USD |
---|---|
Change | -0.17% |
1-year price change | -41.65% |
Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of ITK inhibition as a new approach to immunotherapy for a range of cancer and immune diseases. Its lead product candidate is soquelitini ...
Capitalization | 138 M USD |
---|---|
Change | -1.81% |
1-year price change | +23.30% |
T&G Global Limited is a grower, distributor, marketer and exporter of fresh produce, which includes apples, berries, citrus (lemons, mandarins and navel oranges) and tomatoes. The Company's segments include Apples, International Trading, T&G Fresh, Ventur ...
Capitalization | 129 M USD |
---|---|
Change | +2.94% |
1-year price change | -11.17% |
2seventy bio, Inc. is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The Company is focused on the commercialization and development of Abecma (idecabtagene vicleucel). ...
Capitalization | 215 M USD |
---|---|
Change | +2.87% |
1-year price change | +0.70% |
CARsgen Therapeutics Holdings Ltd is a China-based investment holding company principally engaged in discovering, developing and commercializing innovative chimeric antigen receptor (CAR)-T cell therapies. The Companyâs therapies are applied in the trea ...
Capitalization | 525 M USD |
---|---|
Change | -4.86% |
1-year price change | +2.46% |
Prescient Therapeutics Limited is an Australia-based clinical-stage oncology company. The Company is developing personalized medicine approaches to cancer, including targeted and cellular therapies. Its product pipeline includes PTX-100, PTX-200, OmniCAR, ...
Capitalization | 25 M USD |
---|---|
Change | -2.13% |
1-year price change | -25.81% |
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company focused on developing novel conditionally activated biologics designed to be localized to the tumor microenvironment. It is advancing potential first-in-class and be ...
Capitalization | 136 M USD |
---|---|
Change | -4.00% |
1-year price change | +8.39% |
Sana Biotechnology, Inc. is a biotechnology company focusing on utilizing engineered cells as medicines. It is engaged in developing cell engineering programs to revolutionize treatment across an array of therapeutic areas with unmet treatment needs, incl ...
Capitalization | 1 730 M USD |
---|---|
Change | -3.97% |
1-year price change | +83.82% |
AlloVir, Inc. is an allogeneic T cell immunotherapy company with a focus on restoring natural immunity against life-threatening viral diseases in pediatric and adult patients with weakened immune systems. The companyâs proprietary technology platforms l ...
Capitalization | 85 M USD |
---|---|
Change | +4.12% |
1-year price change | +14.22% |
Kineta, Inc. is a clinical-stage biotechnology company. The Company has leveraged its expertise in innate immunity and is focused on discovering and developing potentially differentiated immunotherapies that address the mechanisms of cancer immune resista ...
Capitalization | 5 M USD |
---|---|
Change | -9.85% |
1-year price change | -88.15% |
NexImmune, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing an approach to immunotherapy designed to employ the bodyâs own T cells to generate an immune response that mimics natural biology. Its product candidates inc ...
Capitalization | 4 M USD |
---|---|
Change | +1.94% |
1-year price change | +42.34% |
Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing Lymphocyte Activation Gene (LAG)-3 immunotherapies for cancer and autoimmune diseases. Its lead product candidate, Eftilagimod alpha (efti or ...
Capitalization | 357 M USD |
---|---|
Change | -8.33% |
1-year price change | +19.57% |
Cartesian Therapeutics, Inc. is a clinical-stage company. The Company is engaged in developing messenger ribonucleic acids (mRNA) cell therapies for the treatment of autoimmune diseases. It is leveraging its proprietary technology and manufacturing platfo ...
Capitalization | 641 M USD |
---|---|
Change | -0.49% |
1-year price change | +73.22% |
Trimurthi Limited is an India-based company, which is engaged in the business of trading of pharmaceuticals and related products and is into the business of trading of shares and securities. The Company's segments include Pharma Business, Financial Servic ...
Capitalization | 2 M USD |
---|---|
Change | 0.00% |
1-year price change | +60.36% |
Elicera Therapeutics AB is a Sweden-based clinical-stage immuno-oncology company. The Company is developing next-generation cell and gene therapies for immune-based treatment of cancer. The company is developing four drug candidates, two of which are in t ...
Capitalization | 4 M USD |
---|---|
Change | -2.23% |
1-year price change | -75.99% |
Lyell Immunopharma, Inc. is a clinical-stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors. The Company is engaged in enrolling a Phase I clinical trial evaluating a ROR1-targeted CAR T-cell the ...
Capitalization | 673 M USD |
---|---|
Change | -5.68% |
1-year price change | +28.35% |
Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first ...
Capitalization | 72 M USD |
---|---|
Change | -3.09% |
1-year price change | +39.90% |
Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company. The Company is focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its pipeline includes CHM 1101 and CHM 2101. I ...
Capitalization | 11 M USD |
---|---|
Change | -15.79% |
1-year price change | -54.29% |
ViGenCell Inc is a Korea-based company principally engaged in the development of cell therapy business. The Company is engaged in the development and manufacture of immuno-cancer cell therapy products and immunosuppressive cell therapy products. In additi ...
Capitalization | 61 M USD |
---|---|
Change | +0.34% |
1-year price change | -25.38% |
Cell Source, Inc. is a cell therapy company focused on immunotherapy. The Company is primarily focused on the development of immune system management technology (Veto Cell technology). Its lead prospective product is its Veto Cell immune system management ...
Capitalization | 32 815 USD |
---|---|
Change | +300.00% |
1-year price change | -99.83% |
ALX Oncology Holdings Inc. is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 immune checkpoint inhibitor and bridge the innate and adaptive immune system. Its product candidate ...
Capitalization | 467 M USD |
---|---|
Change | -6.58% |
1-year price change | -43.79% |
Shine-On BioMedical Co Ltd is a Taiwan-based company mainly engaged in the research, development and manufacture of anti-cancer related new drug products. Antibody products include trispecific T cell engaging nanobody (SOA101), EphA10 trispecific antibody ...
Capitalization | 99 M USD |
---|---|
Change | +0.78% |
1-year price change | -6.34% |
Foxtron Vehicle Technologies Co Ltd is a Taiwan-based company mainly engaged in the research and development of electric vehicle technology, the manufacture, management and sale of vehicle and component. The company's main products include an open platfor ...
Capitalization | 2 423 M USD |
---|---|
Change | +0.11% |
1-year price change | +1.01% |
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells. The Company's platform, Immuno-STAT (Selective Targeting and Alteration of T cells) and b ...
Capitalization | 80 M USD |
---|---|
Change | -6.06% |
1-year price change | -41.29% |
Caribou Biosciences, Inc. is a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It is engaged in developing transformative therapies for patients with devastating diseases. Its gen ...
Capitalization | 194 M USD |
---|---|
Change | +0.70% |
1-year price change | -62.30% |
Janux Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. It has developed two bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr) ...
Capitalization | 2 850 M USD |
---|---|
Change | -11.70% |
1-year price change | +352.47% |
Tevogen Bio Holdings Inc. is a clinical-stage specialty immunotherapy company. The Company is harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs), to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious ...
Capitalization | 132 M USD |
---|---|
Change | -0.93% |
1-year price change | -92.95% |
Eutilex Co., Ltd. is a Korea-based company mainly engaged in the production and sale of immunotherapy products. Major products include anticancer T cell therapies and antibody therapies. ...
Capitalization | 59 M USD |
---|---|
Change | -2.05% |
1-year price change | -36.24% |
Poltreg SA is a Poland-based company engaged primarily in biotechnology and medical research. The Company conducts research in the field of autoimmunological diseases. The Company works on a method of healing, that uses t-regulated cells (TREGs). The Firm ...
Capitalization | 55 M USD |
---|---|
Change | -1.29% |
1-year price change | -7.63% |
Ultimovacs ASA is a Norway-based pharmaceutical company developing immunotherapies against cancer. Ultimovacsâ technology is based on preclinical and clinical research on immunotherapies conducted at the Oslo University Hospital. Ultimovacs is advancing ...
Capitalization | 27 M USD |
---|---|
Change | -8.55% |
1-year price change | -93.90% |
Teletouch Communications, Inc. (Teletouch) offers a suite of telecommunications products and services, including cellular, two-way radio, global positioning system (GPS)-telemetry, wireless messaging and public safety equipment. The Company is an authoriz ...
Capitalization | 49 USD |
---|---|
Change | -.--% |
1-year price change | -.--% |
NeoImmuneTech, Inc. is a clinical-stage T cell-focused biopharmaceutical company. The Company is engaged in the discovery and development of immuno-therapeutics. Its lead asset includes NT-I7 (efineptakin alfa), which is a T Cell Amplifier. NT-I7 is a hum ...
Capitalization | 27 M USD |
---|---|
Change | -7.61% |
1-year price change | -14.27% |
Noile-Immune Biotech Inc is a Japan-based company mainly engaged in the development of chimeric antigen receptor T (CAR-T) cell therapy for solid tumors using proprietary technology. The Cancer Immunotherapy Drug Discovery Business segment develops variou ...
Capitalization | 36 M USD |
---|---|
Change | +35.82% |
1-year price change | -14.15% |
T Scientific Co Ltd, formerly Omnitel Inc, is a Korea-based company mainly engaged in the provision of mobile coupons. The Company mainly sells mobile gift certificates and provides mobile commerce solution services. ...
Capitalization | 68 M USD |
---|---|
Change | -2.07% |
1-year price change | -23.79% |
IO Biotech Inc is a clinical-stage biopharmaceutical company developing immune-modulating cancer therapies based on T-win technology platform. The Companyâs product candidates are designed to induce the immune system to simultaneously target and disrupt ...
Capitalization | 80 M USD |
---|---|
Change | -2.46% |
1-year price change | -36.70% |
- Stock Market
- Advanced search
- Bernd T�njes
- Company Profiles